Skip to main content
logo
3D Medicines Inc. (HKG:1244)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.470
+0.210 (9.29%)
Sep 18, 2026, 4:08 PM HKT

3D Medicines Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
357.44356.09445.65634.95567.3960.26
Revenue Growth
0.38%-20.10%-29.81%11.91%841.57%-
Gross Profit
297.4298.97371.74524.01465.2148.83
Operating Income
-183.63-206.34-230.74-497.25-386.17-520.53
Net Income
-173.41-177.53-182.66-524.7-1,024-1,434
Earnings Per Share
-0.71-0.72-0.75-2.30-22.52-36.72
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
394.66437.91840.98996.58942.03824.48
Total Debt
171.39152.78237.62282.43175.73,192
Net Cash (Debt)
223.28285.13603.36714.15766.33-2,367
Net Cash Growth
-21.69%-52.74%-15.51%-6.81%--
Net Cash Per Share
0.911.162.463.1316.85-60.61

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--159.26-210.58-144.41-278.78-377.08
Capital Expenditures
--0.02-45.36-6.32-53.98-43.87
Free Cash Flow
--159.28-255.94-150.74-332.76-420.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
83.20%83.96%83.41%82.53%81.99%81.03%
Operating Margin
-51.37%-57.95%-51.78%-78.31%-68.06%-863.81%
Pretax Margin
-50.57%-51.94%-44.74%-88.58%-185.42%-2425.86%
Profit Margin
-48.51%-49.86%-40.99%-82.64%-180.54%-2379.84%
FCF Margin
--44.73%-57.43%-23.74%-58.65%-698.56%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.473.301.592.4814.80-